Anti-human immunodeficiency and anti-hepatitis B virus activities of β-l-2′,3′-dideoxy purine nucleosides

Pascal J. Bolon, Peiyuan Wang, Chung K. Chu, Gilles Gosselin, V. Boudou, Claire Pierra, Christophe Mathé, Jean‐Louis Imbach, Abdesselem Faraj, Moulay Abdelaziz El Alaoui,

Bioorganic & Medicinal Chemistry Letters · 1996 · 55 citations · 19 references

DOIFull text

Open access

Concepts

Abstract

β-l-2′,3′-Dideoxyadenosine, β-l-2′,3′-didehydro-2′,3′-dideoxyadenosine and related compounds were synthesized in a stereoselective manner. These compounds were tested in vitro against HBV in 2.2.15 cell line and against HIV-1 in PBM and CEM cells. It was found that β-l-2′,3′-dideohydro-2′,3′-dideoxyadenosine (7) exhibited significant anti-HIV (EC50 0.38 μM in PBM cells) and anti-HBV activity (EC50 1.2 μM).

References

19